Pharmaceutical Marketing: Report on Education on Pharmaceutical Promotion in Medical Training

Report | 19 December, 2017 | Download PDF

The content of this report has been informed, inter alia, by the workshop ‘Education on pharmaceutical promotion in medical training’, organised by Health Action International (HAI), which took place in Amsterdam on 7 September 2017.
Medicines are intended to prevent or cure medical conditions,

Health Action International and European Public Health Alliance Reaction to Leaked Documents from EU-Mercosur Trade Talks

Statement | 7 December, 2017 | Download PDF

Health Action International (HAI) and the European Public Health Alliance (EPHA) issued a joint reaction following Wednesday’s publication of leaked negotiating texts from the European Union (EU) – Mercosur trade talks by Greenpeace.

Read more…

Joint Letter on the Final Phases of EU-Mercosur Trade Talks

Joint Letter | 1 December, 2017 | Download PDF

Health Action International (HAI) has co-signed a letter to Chief Negotiators in the EU-Mercosur trade talks to express our shared concerns about the negative impact of Intellectual Property (IP) clauses on access to medicines.

Read the letter here

Health Action International Launches Programme to Improve Snakebite Situation in Kenya

Media Backgrounder | 23 November, 2017 | Download PDF

Free snakebite emergency information poster available in Kilifi County

NAIROBI—Health Action International (HAI) today launched a new research, education and advocacy programme in Kenya in an effort to reduce the number of snakebite deaths and injuries in the country.

Health Action International Statement on World Health Organization’s General Programme of Work

Intervention/Statement | 22 November, 2017 |  Download PDF

Stichting Health Action International (HAI) welcomes the World Health Organization’s (WHO) General Programme of Work and the opportunity to comment on this important milestone.

As the Programme of Work notes, access to quality-assured medicines plays a crucial role in improving and expanding Universal Health Coverage and notes that the high cost of medicines remains prohibitive for far too many people.

Recommendations on a New Model for the Provision of Scientific Advice

Joint Policy Brief | 21 November, 2017 | Download PDF

Safe and effective medicines that benefit patients
Drug development requires appropriate scientific standards to ensure safe and effective medicines that benefit patients and a high level of human health protection required by the article 168-1 of Treaty on the functioning of the European Union.

HAI Consultation Response on World Health Organization’s 13th General Programme of Work (GPW13)

Consultation Response | 13 November, 2017 | Download PDF

Health Action International (HAI) welcomes the opportunity to contribute to the consultation process on the World Health Organization’s (WHO) General Programme of Work (GPW13).
We note positively the emphasis on promoting Universal Health Coverage (UHC) and the willingness to align WHO within the framework of the Sustainable Development Goals (SDG).

Joint Letter to Jeremy Hunt – Environmental Pollution at Pharma Factories

Joint Letter | 6 November, 2017 | Download PDF

To: Jeremy Hunt, Secretary of State for Health, Government of the United Kingdom

Dear Mr Hunt,

We are writing to you from the Changing Markets Foundation, Health Action International
(HAI), the European Public Health Alliance (EPHA), Health Care Without Harm Europe and
the Alliance to Save Our Antibiotics,

START TYPING AND PRESS ENTER TO SEARCH